LeMaitre Vascular Inc. (LMAT)
101.17
-1.98 (-1.92%)
At close: Feb 20, 2025, 3:59 PM
100.92
-0.24%
After-hours: Feb 20, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 98.12 |
| Market Cap | 2.27B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 1.82 |
| PE Ratio (ttm) | 55.59 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 103.73 |
| Volume | 155,220 |
| Avg. Volume (20D) | 178,982.6 |
| Open | 102.16 |
| Previous Close | 103.15 |
| Day's Range | 99.55 - 102.15 |
| 52-Week Range | 59.87 - 109.58 |
| Beta | undefined |
About LMAT
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vas...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Oct 19, 2006
Employees 614
Stock Exchange NASDAQ
Ticker Symbol LMAT
Website https://www.lemaitre.com
Analyst Forecast
According to 7 analyst ratings, the average rating for LMAT stock is "Buy." The 12-month stock price forecast is $95.5, which is a decrease of -5.60% from the latest price.
Buy 71.43%
Hold 28.57%
Sell 0.00%
Next Earnings Release
LeMaitre Vascular Inc. is scheduled to release its earnings on Feb 27, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+7.34%
LeMaitre Vascular shares are trading higher after ...
Unlock content with
Pro Subscription
9 months ago
+11.16%
LeMaitre Vascular shares are trading higher after the company reported strong Q1 earnings and issued EPS guidance above estimates.
